Posts

Glenmark becomes the First Company in India to launch Teneligliptin + Dapagliflozin Fixed-Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities

Posted by
0

'Glenmark' becomes the First Pharmaceutical Company to launch Lobeglitazone in India for Uncontrolled Type 2 Diabetes in Adults

Posted by
0